Journal of Advanced Research

Researchers at National Taiwan University refined a pseudo-germ-free mouse model to make gut microbiome studies safer for mice and more reliable. Using this model, they found that antibiotic-driven changes in gut microbes suppressed pancreatic tumor growth and enhanced the effect of gemcitabine chemotherapy.